| 翻訳と辞書 |
| Pledge to Africa Act ： ウィキペディア英語版 |
Pledge to Africa Act
The Jean Chrétien Pledge to Africa Act (in full: ''An Act to amend the Patent Act and the Food and Drugs Act''), a key piece of legislation implementing Canada's Access to Medicines Regime, was a bill introduced as C-9 in the third session of the 37th Canadian Parliament. It represented the first implementation of the TRIPS flexibilities declared in the August 30, 2003, General Council decision. Enacted in May 2004, it allows Canada to enact compulsory licenses to export essential medicines to countries without the capacity to manufacture their own. Other countries that have since enacted similar legislation include Norway and India.
==Purpose==
The purpose of the Act is to improve access to drugs for developing countries that lack the resources to manufacture the drugs and cannot afford to buy them at the usual market cost.〔http://www.stephenlewisfoundation.org/documents/SLFNewsletter2005.pdf〕 The drugs that fight these diseases are expensive to create and manufacture and thus are usually unaffordable for those who need them the most.〔(The Jean Chrétien Pledge to Africa Act: Patent Law and Humanitarian Aid )〕
The Pledge to Africa Act allows for the patents on these drugs to be overridden so that manufacturers can produce generic versions of the drug to sell in underdeveloped countries.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Pledge to Africa Act」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|